Role of isolated ultrafiltration in the management of chronic refractory and acute decompensated heart failure.
Chronic congestive heart failure (CHF) and acute decompensated heart failure (ADHF) refractory to medical therapy represent therapeutic challenges. In such patients, attempts to reduce pulmonary and systemic congestion frequently produce deterioration of renal function. In studies of patients with chronic severe CHF refractory to medical therapy (including loop diuretics), isolated ultrafiltration was frequently able to relieve congestive symptoms by precise removal of extracellular water and sodium, and in some cases was able to restore responsiveness to loop diuretics. Randomized controlled trials comparing isolated ultrafiltration and medical therapy (mainly loop diuretics) in patients with ADHF failed to demonstrate the superiority of isolated ultrafiltration over diuretic therapy with respect to renal function and mortality. Isolated ultrafiltration reduced length of hospital stay in several studies. At this time, there is insufficient evidence to support the use of isolated ultrafiltration as initial therapy of ADHF.
Division of Cardiovascular Medicine, University of Missouri School of Medicine, Columbia, Missouri, USA.
Mayank K
MK
Mittal
Division of Cardiovascular Medicine, University of Missouri School of Medicine, Columbia, Missouri, USA.
Natraj
N
Katta
Division of Cardiovascular Medicine, University of Missouri School of Medicine, Columbia, Missouri, USA. alpertm@health.missouri.edu.
Martin A
MA
Alpert
Refractory chronic congestive heart failure; cardiorenal syndrome; isolated ultrafiltration; loop diuretic; refractory acute decompensated heart failure